Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes

Frontiers in Pediatrics

article

Julia Fuchs¹  Roman Hovorka¹ 

[1] Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, United Kingdom;Department of Paediatrics, University of Cambridge, United Kingdom

关键词: diabetes technology;    young people;    type 1 diabetes (or diabetes);    closed-loop insulin delivery;    artificial pancreas (AP);    children;   

DOI  :  10.3389/fped.2021.679484

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Recent advances in diabetes technology have led to the development of closed-loop insulin delivery systems for the management of type 1 diabetes. Several such systems are now commercially available for children and young people. While all available systems have been shown to improve glycaemic control and quality of life in this population, qualitative data also highlights the challenges in using closed-loop systems, which vary among different pediatric age-groups. Very young children require systems that are able to cope with low insulin doses and significant glycaemic variability due to their high insulin sensitivity and unpredictable eating and exercise patterns. Adolescents' compliance is often related to size and number of devices, usability of the systems, need for calibrations, and their ability to interact with the system. Given the speed of innovations, understanding the capabilities and key similarities and differences of current systems can be challenging for healthcare professionals, caregivers and young people with type 1 diabetes alike. The aim of this review is to summarize the key evidence on currently available closed-loop systems for children and young people with type 1 diabetes, as well as commenting on user experience, where real-world data are available. We present findings on a system-basis, as well as identifying specific challenges in different pediatric age-groups and commenting on how current systems might address these. Finally, we identify areas for future research with regards to closed-loop technology tailored for pediatric use and how these might inform reimbursement and alleviate disease burden.

【 授权许可】

CC BY